Literature DB >> 15232190

Evaluation of gastrointestinal symptoms as primary sign of severe invasive group A streptococcal infections.

K Ekelund1, A Lemcke, H B Konradsen.   

Abstract

BACKGROUND &
OBJECTIVES: Severe invasive infections caused by group A Streptococcus (GAS) are often associated with shock and organ failure. We describe epidemiological and disease related data from the national surveillance of invasive GAS infection in Denmark in addition to three fatal cases that occurred in Denmark in 2002 with gastrointestinal (GI) symptoms as the dominating preliminary signs.
METHODS: As the National Streptococcal Reference Centre The Streptococcus Unit, Statens Serum Institut (SSI) receives the vast majority of the invasive GAS isolates from patients admitted to all the hospitals in Denmark. The isolates were T-typed by slide agglutination test emm-squencing and pulsed field gel electrophoresis (PFGE) were also performed.
RESULTS: During January 2002 three patients died at home and GAS were found at autopsy. Cases 1 (12 yr) and 3 (25 yr) had been ill for less than two days with nausea, diarrhoea and vomiting. Case 2 (25 yr) had the same symptoms for two weeks. None of the three had any underlying diseases. The GAS isolates from cases 1 and 2 were T-type 3-13-B3264, emm89 and SpeA-, SpeC-. The third isolate was Ttype 1, emm1 and SpeA+, SpeC-. PFGE could not discriminate between the two isolates with T-type 3-13-B3264. The PFGE patterns of the three isolates were similar to those identified from GAS isolated elsewhere in Denmark at different times and from non-fatal cases. In 1999-2002, SSI received 409 isolates from patients with invasive GAS infection, and the mortality rate was 18 per cent. In 40 patients the primary symptoms were gastrointestinal, and in 30 per cent of these the outcome was fatal. INTERPRETATION &
CONCLUSION: The various early clinical manifestations of severe GAS infections are still a major challenge for clinicians because of the importance of a fast and appropriate diagnosis and immediate start of treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15232190

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  2 in total

1.  Rapid Emergence of a New Clone Impacts the Population at Risk and Increases the Incidence of Type emm89 Group A Streptococcus Invasive Disease.

Authors:  Sarah Teatero; Brenda L Coleman; Stephen B Beres; Randall J Olsen; Christopher Kandel; Olivia Reynolds; Taryn B T Athey; James M Musser; Allison McGeer; Nahuel Fittipaldi
Journal:  Open Forum Infect Dis       Date:  2017-03-04       Impact factor: 3.835

Review 2.  Diarrhea caused by primarily non-gastrointestinal infections.

Authors:  Emil C Reisinger; Carlos Fritzsche; Robert Krause; Guenter J Krejs
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2005-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.